tiprankstipranks
Advertisement
Advertisement
Jaguar Animal Health Granted Short Nasdaq Compliance Extension
PremiumCompany AnnouncementsJaguar Animal Health Granted Short Nasdaq Compliance Extension
14d ago
Jaguar Health’s Napo held preliminary discussion with FDA over crofelemer
Premium
The Fly
Jaguar Health’s Napo held preliminary discussion with FDA over crofelemer
14d ago
Jaguar Health Boosts Public Float to Regain Nasdaq Compliance
Premium
Company Announcements
Jaguar Health Boosts Public Float to Regain Nasdaq Compliance
16d ago
Jaguar Health granted extension to demonstrate compliance with Nasdaq bid rule
PremiumThe FlyJaguar Health granted extension to demonstrate compliance with Nasdaq bid rule
24d ago
Jaguar Health announces 1-for-35 reverse stock split
Premium
The Fly
Jaguar Health announces 1-for-35 reverse stock split
24d ago
Jaguar Health Enacts Reverse Split to Maintain Nasdaq Listing
Premium
Company Announcements
Jaguar Health Enacts Reverse Split to Maintain Nasdaq Listing
24d ago
Jaguar Health completes effectiveness study of crofelemer tablets
PremiumThe FlyJaguar Health completes effectiveness study of crofelemer tablets
1M ago
Jaguar Health reports FY25 EPS ($24.27) vs. ($130.69) last year
Premium
The Fly
Jaguar Health reports FY25 EPS ($24.27) vs. ($130.69) last year
1M ago
Jaguar Health Delays Annual Form 10-K Filing
Premium
Company Announcements
Jaguar Health Delays Annual Form 10-K Filing
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100